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binding and toxicity. Peptides corresponding to loops a8, 1 and 3, but not loop 2, competed with
toxin binding to Aedes midgut membranes. Mutagenesis data reveal loops a8, 1 and 3 are involved
in toxicity. Loops 1 and 3 are of greater signiﬁcance in toxicity to Aedes and Culex larvae than to
Anopheles. Cry11Ba binds the apical membrane of larval caecae and posterior midgut, and binding
can be competed by loop 1 but not by loop 2 peptides. Cry11Ba binds the same regions to which anti-
cadherin antibody binds, and this antibody competes with Cry11Ba binding suggesting a possible
role of cadherin in toxication.
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In an effort to develop environmentally responsible methods of
mosquito control, researchers have been evaluating microbiologi-
cal control strategies involving mainly Bacillus thuringiensis sub-
species israelensis or B. sphaericus. Both bacterial species produce
insecticidal inclusions. Subspecies israelensis produces four major
insecticidal proteins, classiﬁed as Cry4Aa, Cry4Ba, Cry11Aa, and
CytlAa, all of which are toxic to mosquito larvae [1,2]. However,
a number of other B. thuringiensis strains producing Cry toxins have
been identiﬁed including B. thuringiensis subsp. jegathesan [3]. This
Bacillus produces a protein called Cry11Ba, which to date is the
most mosquitocidal single toxin having about 6–40 times more
activity against mosquitoes (depending on the species of mosquito
tested) than the most active toxin of B. thuringiensis subsp. israelen-
sis [2,4]. Consequently, the Cry11Ba toxin provides an alternative
to toxins used in current control programs thereby addressing risk
of potential mosquito resistance development to B. thuringiensis
subspecies israelensis or B. sphaericus toxins.
Like other Cry toxins, mosquitocidal toxins when ingested by
susceptible larvae are processed in the larval alkaline midgut
releasing soluble proteins, which are then activated by digestive
enzymes. For several Cry toxins, it has been shown that the acti-chemical Societies. Published by Evated toxins bind to speciﬁc receptors on the brush border of target
insects. Many putative Cry toxin receptors have been reported and
the best characterized are those in lepidopteran insects. These in-
clude cadherin-like proteins [5–7], glycosylphosphatidyl-inositol
(GPI)-anchored aminopeptidases N (APN) [8,9], a GPI-anchored
alkaline phosphatase (ALP) [10,11] and a 270 kDa glycoconjugate
[12]. Recent work show a similar set of proteins also act as recep-
tors for mosquitocidal toxins, with reports of Cry4Ba binding to
Anopheles gambiae cadherin [13], Cry11Ba binding to APNs from
An. quadrimaculatus and An. gambiae [14,15], and Cry11Aa binding
to ALP from Ae. aegypti [16].
Presently two models of Cry protein toxicity have been pro-
posed. In one, sequential binding to multiple receptors might be
required to induce toxicity [17,18], while in the other binding to
the cadherin alone initiates an intracellular cascade that leads to
cell toxicity [19]. However, in both models binding to speciﬁc
receptors is essential for initiating toxicity. This key binding step
between active three-domain globular proteins and their receptors
has been investigated with many Cry toxins. These reports demon-
strate domain II is involved in receptor recognition and hence in-
sect speciﬁcity [20–23]. Recent reports with mosquitocidal Cry
toxins support the role of domain II in binding receptors in mos-
quito midgut [24,25].
Site-directed mutagenesis approaches have been used by
several research groups to investigate the role of the domain II sur-
face-exposed loops in the toxicity of Cry proteins [23,26–28]. Inlsevier B.V. All rights reserved.
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3) are involved in toxicity and at least two of them (loop 2 and loop
3) are involved in binding ability [23,29–31]. In the Cry3A toxin
loop 1 and loop 3 of domain II are involved in receptor binding
whereas loop 2 double mutations had no effect on binding or
toxicity [32]. To show that the loop regions in domain II of the
Cry11Ba are also involved in binding and toxicity we initially
developed a homology model of Cry11Ba to identify these loop re-
gions. Then using a combination of the four loop peptides (loop a8,
loop 1, loop 2 and loop 3) and site directed triple- and single-amino
acid replacements in the all exposed loops we show loop a8, loop 1
and loop 3 play a role in Cry11Ba mosquitocidal activity. By com-
bining immunohistochemistry and competitive binding assays,
we suggest Cry11Ba toxin binds the cadherin protein in Ae. aegypti.2. Materials and methods
2.1. Homology modeling structure
The secondary structure of Cry11Ba was predicted with Predict-
Protein to compare to the Cry2Aa structure [33] using default
parameters. The exposed loop regions were then identiﬁed using
both Cry2Aa and the predicted loops of Cry11Aa [24]. The Cry11Ba
secondary-structure prediction was threaded against the whole
backbone database using Phyre (web-based program). Top signiﬁ-
cant hits corresponded to Cry protein structures, with the top hit
being Cry2Aa (1i5p.pdb) at 15% homology. The PDB ﬁle produced
by EsyPred 3.1 (web-based program) was used to build a model
with Swiss-pdb 3.51 [34]. Energy minimization levels were also
analyzed to ensure that the run was taken to equilibrium.
2.2. Preparation of Cry11Ba toxins from B. thuringiensis
Cry11Ba was produced in B. thuringiensis harboring a pHT315
plasmid that has the Cry11Ba gene [4]. The bacterial culture was
grown in sporulation medium supplemented with erythromycin
(25 lg/ml) at 30 C for 3 days. Cultures expressing Cry11Ba wild-
type or mutant toxins were harvested by centrifugation and resus-
pended in distilled water. Cells were then washed with 1 M NaCl,
10 mM EDTA 3–4 times. The inclusions were puriﬁed on NaBr gra-
dients [35].
2.3. Toxin puriﬁcation and toxin biotinylation
The puriﬁed inclusions were solubilized by incubation at 37 C
for 4 h in 50 mM Na2CO3, pH 10 and then activated by digestion
with trypsin (phenylalanyl chloromethyl ketone treated) at a ratio
of 1:20 (w/w) enzyme: toxin in 50 mM Na2CO3, pH 10 for l6 h. The
activated toxin was puriﬁed by ion-exchange chromatography
using a MonoQ column (GE Health Care, USA) with a linear gradi-
ent of 50 mM Na2CO3, pH 10.0 and 50 mM Na2CO3, pH 10.0 with
1 M NaCl at a ﬂow rate of 0.4 ml/min. Eluted fractions were col-
lected and concentrated to 1–2 mg/ml by ultraﬁltration at 4 C
using a Ultrafree-CL column (l0-kDa cutoff, Millipore, Bedford,
USA). The puriﬁed and concentrated activated Cry11Ba toxin was
biotinylated using the protein biotinylation module kit (GE Health
Care) and then puriﬁed using a Sephadex G25 column.
2.4. Preparation of brush border membrane vesicles (BBMV)
Midguts were dissected from early fourth instar Ae. aegypti lar-
vae and kept in 80 C until use. BBMV were prepared by the dif-
ferential magnesium precipitation method [36]. The BBMV were
resuspended in the ice-cold buffer A (0.3 M Mannitol/0.5 M
EGTA/20 mM Tri-Cl, pH 8), and the concentration of total proteinwas measured by a BCA kit (Pierce, USA). Alkaline phosphatase
and leucine aminopeptidase activities were determined as previ-
ously described [11,36].
2.5. BBMV binding assays
Binding of Cry11Ba toxin to Aedes BBMV was performed as de-
scribed [24]. BBMV (20 lg protein) were incubated with biotinyla-
ted-Cry11Ba (10 nM) in 100 ll binding buffer (0.1% BSA, 0.1%
Tween 20, PBS pH 7.4) in the presence or absence of cold-Cry11Ba
toxin, loop peptides or puriﬁed mutant Cry11Ba toxins. After incu-
bation for 1 h at room temperature, the mixture was centrifuged at
10000g for 10 min, and the pellet then washed three times with
binding buffer to remove unbound toxins. The washed pellet was
boiled for 5 min in sample buffer and then separated by SDS–PAGE
and electrotransferred to PVDF membranes (Immobilon, Amer-
sham Biosciences). The membranes were incubated with streptavi-
din-peroxidase conjugate (1:2500 dilution, Amersham Biosciences)
for 1 h and then visualized using luminal (ECLTM, Amersham Biosci-
ences). For competitive assays with antibodies, BBMV were
pre-incubated with polyclonal anti-cadherin or anti-Aedes NHE3
antibodies (1/10 or 1/1000 dilutions) for 1 h at room temperature
before incubating with biotinylated-Cry11Ba as described above.
2.6. Binding assays to tissue sections
2.6.1. Tissue preparation
Early fourth instar Ae. aegypti larvae were ﬁxed overnight in 4%
paraformaldehyde (PFA) at 4 C. Then the larvae were washed in
PBST (1 PBS/0.1% Triton X-100) for 30 min three times, dehy-
drated in 20%, 40%, 70%, 96% ethanol series in lxPBST for 30 min
each and ﬁnally in 100% ethanol for 1 h at room temperature
(RT). The samples were placed in ethanol/xylene mixture (70/30,
then 30/70) for 3 h each and then in 100% xylene at room temper-
ature overnight. Paraplast chips (Xtra, Fisher Scientiﬁc) were added
at 20–50% of total 100% xylene volume for 6–8 h at RT and then re-
placed with fresh Paraplast at 56 C over 2 days until tissues were
completely inﬁltrated. The larvae were embedded in Paraplast
blocks and then 8–10 lm thick sections were cut, placed on to
poly-L-lysine (Sigma, St. Louis, MO) slides with 1% gelatin (Becton
Dickson, Franklin Lakes, NJ), and the sections dried for 1–2 days
at 40 C.
2.6.2. Immunolocalization
The sections were dewaxed in 100% xylene for 15 min twice,
rehydrated in 100%, 70%, 40% and 20% ethanol for 5 min each
and rinsed in deionized water and 1 PBST. The tissues were
blocked in 2% BSA/PBST (Bovine Serum Albumin) for 1 h at RT
and then incubated with Cry11Ba toxin (10 nM), in the absence
or presence of competitor loop 1 and loop 2 peptides, in 1% BSA/
PBST. The sections were washed in 0.1% BSA/PBST six times to
eliminate unbounded toxin. The tissues were incubated with pri-
mary anti-Cry 11Ba whole serum antibody diluted 1:100 or
1:250 in PBST/1% BSA at 4 C overnight and then washed in
PBST/0.1% BSA/2% goat serum for 30 min twice. Finally, the sec-
tions were incubated for 1 h in the dark with secondary antibodies
(Jackson Immunoresearch Labs). For Cry11Ba toxin detection Cy3-
conjugated goat-anti-rabbit was diluted 1:1000 and Phalloidin-
Alexa 488 diluted 1:100 was applied for actin F detection. After
washing twice in 0.1% BSA/PBST the sections were mounted in
Shur/Mount media (Electron Microscopy Science, Hatﬁeld, PA).
The images were obtained using laser-scanning confocal Zeiss Axi-
oplan microscope (LSM Zeiss 510, Institute of Integrative Genome
Biology, University of California, Riverside) at 40 and 100 mag-
niﬁcations. All images were imported in Adobe Photoshop (V6) for
assembly and annotation.
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A 2175-bp fragment, carrying the Cry11Ba gene, was PCR-
ampliﬁed from a recombinant Bacillus strain that contained pJeg80
[4] and cloned into pQE30 an Escherichia coli expression vector
(Qiagen Inc.). The recombinant plasmid encoding the 80-kDa
Cry11Ba toxin was analyzed to show toxin expression and toxicity
against mosquito larvae, and this construct was then was used as a
template for site-directed mutagenesis. Thirty-six pairs of comple-
mentary mutagenic oligonucleotides primers (Supplementary
Table 1) were designed and synthesized (Sigma, St. Louis). Triple
and single alanine mutations in loop a8, loop 1, loop 2, and loop
3 were generated by PCR using a high ﬁdelity Pfu DNA polymerase,
following the procedure of the QuickChangeTM Mutagenesis Kit
(Stratagene, La Jolla). All mutant plasmids were veriﬁed by DNA
sequencing (Institute of Integrative Genome Biology, UC Riverside).
2.8. Toxin expression in E. coli, B. thuringiensis and mosquito larvae
toxicity assays
Wild-type and mutant toxins in pQE30 were transformed into
M15 E. coli competent cells for protein expression. Bacterial clones
harboring the wild-type plasmid or mutants were grown at 37 C
in Luria-Bertani medium containing l00 lg/ml ampicillin and
50 lg/ml kanamycin until the OD600 of the culture reached 0.3–
0.5. Protein expressionwas inducedwith isopropyl-b-D-thiogalacto-
pyranoside (IPTG) at a ﬁnal concentration of 0.1 mM for 4 h and
subsequently analyzed by sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS–PAGE) at l0% w/v. B. thuringiensis cultures
expressing Cry11Ba wild-type and mutant toxins in pHT3l5 were
harvested and the inclusions were puriﬁed by NaBr gradients as
described above.
Bioassays for mosquito-larvicidal activity were performed with
fourth instars of Ae. aegypti, An. stephensi, and Culex quinquefascia-
tus larvae (University of California Riverside). The bioassays were
performed 3–5 times. Brieﬂy, 20 early fourth instar larvae were
placed in water in a 6-oz plastic cup (5 cm cup diameter, Costar,
USA) to which an E. coli suspension of approximately 1  108 cells
suspended in distilled water was added to a total volume of
200 ml. E. coli M15 cells were used as a negative control. Mortality
was recorded after 24-h incubation at room temperature. All bioas-
says were examined and repeated at least three times. Data ob-
tained for LC50 and LC95 determinations were statistically
evaluated using Finney’s Probit Analysis.
2.9. Puriﬁcation of the E. coli expressed Cry11Ba and mutant toxins
E. coli cultures over expressing the toxins as cytoplasmic inclu-
sions were harvested by centrifugation and resuspended in cold
distilled water. Cells were then disrupted by sonication for
10 min (Soniﬁer 450, USA). After centrifugation at 10000g, 4 C
for 10 min, the pellets were washed three times in 1% Triton
X-l00 and suspended by sonication. Protein concentrations of the
partially puriﬁed inclusions were determined by using a BCA kit
(Pierce, USA). Inclusions (1–2 mg/ml) were solubilized by incuba-
tion at 37 C for 2–3 h in 50 mM Na2CO3, pH 10 and then activated
as described above using trypsin. The activated toxins were puri-
ﬁed by FPLC as described above.
2.10. Analysis of toxin structure by circular dichroism (CD)
CD spectra of activated toxins were obtained using a Jasco J-715
CD spectropolarimeter (Core Analytical Chemistry Instrumentation
Facility, UC Riverside) in the far UV region (190–260 nm) using a
rectangular quartz cuvette. Samples were prepared in 50 mM
Na2CO3, pH 10.0, with protein concentrations of 0.10 mg/ml, asdetermined by far UV absorbance. CD spectra were recorded at a
scanning rate of 100 nm/min with a spectral bandwidth of 1 nm
and response times of 1 ms. Eight data accumulations were taken
and the results averaged. After background subtraction, all the
CD data were converted from CD signal (mdeg) into mean residue
ellipticity (deg cm2/dmol).
3. Results
3.1. Cry11Ba structure prediction
Because there was no structural information of the Cry11Ba
toxin, we used available Cry toxin structures to predict its struc-
ture. The structures of Cry1Aa [20], Cry2Aa [33], Cry3Ba [37],
Cry4Aa [38] and Cry4Ba [39] have been reported since the Cry3Aa
toxin crystal structure was ﬁrst elucidated [21]. Of these structures
Cry2Aa has the highest amino acid sequence similarity to Cry11Ba,
and based on this homology, a Cry11Ba structure was built with
three domains. To more precisely predict the loop regions within
domain II we compared the Cry11Ba protein with the secondary
structure of Cry2Aa and that of the predicted Cry11Aa [24] using
Phyre and PredictProtein [40,41]. The predicted loops a8, 1, 2
and 3 are shown in Fig. 1A. Together with these variable loops
the predicted Cry11Ba structure is shown in Fig. 1B.
3.2. Binding of Cry11Ba toxin to BBMV
Cry11Ba inclusions were puriﬁed from the pJeg80 containing B.
thuringiensis strain using NaBr gradients [4,42]. Upon activation
the 65-kDa Cry11Ba toxin generated 30- and 35-kDa fragments.
The activated toxin 30- and 35-kDa proteins were labeled with bio-
tin and then analyzed for toxin binding to Ae. aegypti BBMV. Fig. 2
shows the binding of biotinylated-Cry11Ba toxin can be competed
by excess unlabeled Cry11Ba. At a molar ratio of 1:1 of labeled to
unlabeled, the unlabeled toxin initially competed with binding of
the 35-kDa fragment followed by competitionwith the 30 kDa frag-
ment. At a ratio of 1:50 and higher, binding to both fragments of the
biotinylated-Cry11Ba was nearly completely competed (data not
shown).
3.3. Competitive binding assays in the presence of loop peptides
To determinewhether the predicted loop regions are involved in
binding ability, four synthetic peptides (a8, L1, L2 and L3) corre-
sponding to the putative loop regions (loop a8, loop 1, loop 2 and
loop 3) of Cry11Ba (see Fig. 1A) were synthesized and used to com-
pete with binding of biotinylated-Cry11Ba to larval midgut BBMV.
As shown in Fig. 2, three peptides corresponding to loop a8, loop 1
and loop 3 were found to compete the binding of Cry11Ba to BBMV.
Whereas peptide corresponding to loop 2 (Fig. 2, lane 6) as well as
the negative control peptide NHE8 (Fig. 2, lane 12) derived from
AedesNHE ion exchanger protein [43] did not competewithCry11Ba
binding. The data suggests three-domain II loops, loopa8, loop1 and
loop 3, are involved in Cry11Ba toxin binding to Aedes BBMV.
We also analyzed the percentage of toxin binding to BBMV of
both the 35- and 30-kDa Cry11Ba fragments in the presence of
different competitors. Table 1 shows the 35-kDa fragment of bio-
tinylated-Cry11Ba toxin was more readily competed off than the
30-kDa fragment with almost all competitors. Of the competitors
used, loop 3 peptide seemed to compete best with Cry11Ba binding
to BBMV (Fig. 2, Table 1).
3.4. Effect of loop mutations on mosquitocidal toxicity
Since at least three loop region peptides competed with Cry11-
Ba binding to midgut BBMV form Ae. aegypti larvae, we then
AB
Fig. 1. Modeling of Cry11Ba and the predicted loop regions from multiple alignment of loop regions with several cry toxins. (A) Amino acid alignment of domain II of
Cry11Aa, Cry11Ba and Cry2Aa toxins (generated by using MAFFT V. 5.743). Underlined regions correspond to loop residues in the Cry toxins. (B) 3D-structural model of
Cry11Ba, which was obtained based on alignment in the structure of Cry2Aa toxin. The predicted loop regions are indicated as blue loop a8; red, loop 1; purple, loop 2; and
yellow, loop 3.
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Fig. 2. Unlabeled Cry11Ba, loop peptides and a mutant Cry11Ba compete with biotinylated-Cry11Ba toxin binding to Aedes larval midgut BBMV. Competition of varying
molar excess of unlabeled Cry11Ba (lanes 2, 3 and 9), four loop peptides (lanes 4–7), mutant Cry11Ba toxin (lanes 10 and 11) and with a control NHE8 peptide (lane 12) with
biotinylated-Cry11Ba binding to BBMV. Synthetic loop peptides, a8, L1, L2 and L3, were used in lanes 4–7, respectively. Puriﬁed mutant toxins L1-H307A and R303A/E304A/
N305were used in lanes 10 and 11, respectively. In lane 12 an unrelated peptide, NHE8, used as a control does not compete with biotinylated-Cry11Ba binding to BBMV.
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volved in toxicity. All residues in the predicted loop a8, loop 1, loop
2, and loop 3 were changed to alanine via PCR-based site-directed
mutagenesis. In an initial screen three residues were mutated at a
time. The mutant protoxins were highly expressed in E. coli M15cells upon IPTG induction, with yields similar to the wild-type
Cry11Ba toxin, except the loop 1 N305A mutant showed no protein
expression (data not shown). To determine mutational effects
on toxicity, fourth instar larvae of Ae. aegypti, An. stephensi and
C. quinquefasciatus, were fed E. coli cells expressing each mutant
Table 1
Loop region peptides and mutant toxins preferentially compete with the domain II and III of Cry11Ba binding to BBMV.
Competitor peptide Domain II–III 35-kDa fragment Domain I 30-kDa fragment
1:1 1:100 1:250 1:1 1:100 1:250
Percentage of toxin binding of Cry 11Ba
Cry11Ba toxin 21 9 – 87 11 –
Peptide a8 – – 14 – – 39
Peptide L1 – – 8 – – 7
Peptide L2 – – 77 – – 92
Peptide L3 – – 2 – – 15
Peptide NHE8 – – 95 – – 86
H307A – 5 – – 36 –
R303A/E304A/N305A – 10 – – 43 –
Competitor peptides were used at 1:1, 1:100 or 1:250 molar ratio excess of Cry11Ba. Values are percent of Cry11Ba binding to BBMV in the presence of competitor peptides.
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the toxicity of three triple mutants (V256A/G257A/E258A,
N262A/I263A/S264A, and W268A/K269A/G270A) on loop a8 and
a few from loop 1 (R303A/E304A/N305A and I306A/H307A/G308A)
and loop 3 (L451A/T452A/Y453 and N454A/K455A/L456A) were
reduced by 80–100% against Ae. aegypti (Table 2). On the other
hand, it was interesting to note that only two mutants (V256A/
G257A/E258A and W268A/K269A/G270A) on loop a8 exhibited
substantially reduced larvicidal activity against An. stephensi,
whereas the ﬁve other mutants had signiﬁcant toxicity. In contrast
results from bioassays performed on Culex are more similar to
those against Aedes, showing toxin mutants in loop a8, loop 1Table 2
Toxicity of wild-type and Cry11Ba mutant proteins expressed from E. coli against
fourth instar larvae of Ae. aegypti, An. stephensi and C. quinquefasciatus.
Toxins Mortality (%)
Ae. aegypti An. stephensi C. quinquefasciatus
M15 0 ± 0 0 ± 0 0
Cry11Ba wild-type 88 ± 6.01 98 ± 1.67 98 ± 2.88
a8-V256A/G257A/E258A 0 ± 0 3 ± 1.67 0 ± 0
a8-S259A/I260A/N261A 90 ± 2.89 100 ± 0 95 ± 5
a8-N262A/I263A/S264 27 ± 4.41 100 ± 0 72 ± 17.5
a8-P265A/N266A/D267A 82 ± 4.41 100 ± 0 98 ± 2.88
a8-W268A/K269A/G270A 0 ± 0 17 ± 6.61 6 ± 2.88
L1-R303A/E304A/N305A 22 ± 11.67 93 ± 4.41 8 ± 2.88
L1-I306A/H307A/G308A 3 ± 1.67 100 ± 0 86 ± 15.27
L1-V309A/L310A/P311A 92 ± 3.33 100 ± 0 98 ± 2.88
L2-Y291A/F392A/S393A 97 ± 3.33 100 ± 0 96 ± 5.8
L2-P394A/G395A/L396A 72 ± 6.01 100 ± 0 96 ± 5.8
L3-L451A/T452A/Y453A 27 ± 8.82 100 ± 0 23 ± 7.64
L3-N454A/K455A/L456A 23 ± 7.26 98 ± 1.67 33 ± 17.56
L3-E457A/Y458A/D459A 87 ± 1.67 100 ± 0 96 ± 5.8
L3-A460A/P461A/T462A 97 ± 3.33 100 ± 0 95 ± 5
L3-T463A/Q464A/N465A 82 ± 8.82 100 ± 0 93 ± 2.88
a8-V256A 83 ± 1.67 100 ± 0 96 ± 2.88
a8-G257A 2 ± 1.67 33 ± 6.01 3 ± 2.88
a8-E258A 78 ± 3.33 100 ± 0 96 ± 5.77
a8-N262A 90 ± 2.89 100 ± 0 95 ± 5
a8-I263A 0 ± 0 0 ± 0 6 ± 2.88
a8-S264A 0 ± 0 100 ± 0 38 ± 25.2
a8-W268A 88 ± 1.67 98 ± 1.67 96 ± 2.88
a8-K269A 5 ± 2.89 100 ± 0 8 ± 2.88
a8-G270A 83 ± 1.67 98 ± 1.67 96 ± 2.88
L1-R303A 88 ± 6.61 100 ± 0 98 ± 2.88
L1-E304A 75 ± 2.89 92 ± 4.41 96 ± 5.77
L1-N305A NE NE NE
L1-I306A 0 ± 0 100 ± 0 12 ± 5.77
L1-H307A 87 ± 1.67 100 ± 0 96 ± 2.88
L1-G308A 75 ± 2.89 100 ± 0 96 ± 2.88
L3-L451A 90 ± 0 97 ± 3.33 80 ± 5
L3-T452A 92 ± 1.67 98 ± 1.67 92 ± 5.77
L3-Y453A 75 ± 2.89 100 ± 0 95 ± 5
L3-N454A 87 ± 1.67 100 ± 0 92 ± 7.6
L3-K455A 83 ± 1.67 100 ± 0 96 ± 5.77
L3-L456A 87 ± 1.67 100 ± 0 92 ± 7.6and loop 3 were also reduced in toxicity whereas loop 2 mutants
had no effect on toxicity. Single mutations then were made to iden-
tify the critical amino acid residues involved. We found that resi-
dues G257, I263, S246 and K269 on loop a8; residues N305 and
I306 on loop 1 are important for Cry11Ba toxicity. Single mutations
on loop 3 had no effect on toxicity to all three mosquito species
even though the triple mutants were clearly affected in toxicity
as shown in Table 2.
To determine the LC50 and LC95 values of the mutant toxins we
expressed one mutant strain (R303A/E304A/N305) in B. thuringien-
sis (4Q7). Inclusions from this strain and the pJeg80 strain were
used to assess toxicity to larvae of Ae. aegypti, An. stephensi and
C. quinquefasciatus. The wild-type Cry11Ba conferred the highest
toxicity against An. stephensi, with the toxicity being 3.5 times
and 1.5 times greater than to Ae. aegypti and C. quinquefasciatus,
respectively. The R303A/E304A/N305 mutant on the other hand
was severely affected in its toxicity against all three species of lar-
vae, being 1500–3000 times less toxic than that of the wild-type
Cry11Ba toxin (Table 3). In contrast this same mutant when ex-
pressed in E. coli showed 4–l0 times decrease in toxicity than
wild-type Cry11Ba toxin against Ae. aegypti and C. quinquefasciatus,
respectively (Table 2). It is interesting to note the E. coli expressed
R303A/E304A/N305 mutant showed high toxicity to An. stephensi
larvae. However, by changing toxin concentrations in bioassays
we could show the R303A/E304A/N305 mutant was less toxic than
the wild-type Cry11Ba (data not shown). Differences in toxicity ob-
served between B. thuringiensis and E. coli expressed proteins are
likely due to the use of protein mixtures in bioassays in the latter,
and toxin levels could not be quantiﬁed in a crude E. coli mixture.
Hence, only mutants which are severely affected in toxicity are
identiﬁed in Table 2.
3.5. Structural characterization of the puriﬁed mutant toxins
We then selected two mutants, one each from loop a8 (V256A/
G257A/E258A) and loop 3 (N454A/K455A/L456A), which had lower
toxicity against the mosquito larvae to analyze if these toxins are
processed as the wild-type Cry11Ba. Upon solubilization in
50 mM Na2CO3, pH 10.0, the mutant protoxins expressed in
E. coli were puriﬁed by FPLC using ion-exchange chromatography.
The puriﬁed fractions of both wild-type and mutant strains were
concentrated (Fig. 3A, lane 1) and cleaved into 30- and 35-kDa
fragments (Fig. 3A, lanes 2 and 3). This similarity in protein cleav-
age indicates the mutations did not cause protein signiﬁcant mis-
folding and also had no apparent effect on proteolytic processing.
The puriﬁed mutant toxins (V256A/G257A/E258A and N454A/
K455A/L456A) were then examined for its secondary structural
by far-UV CD spectroscopy. The puriﬁed wild-type toxin and
V256A/G257A/E258A mutant exhibited similar CD spectra as the
wild-type toxin (Fig. 3B). Although, the N454A/K455A/L456A mu-
tant gave subtle differences in CD spectrum, it should be noted that
Table 3
Loop 1 Cry11Ba mutant toxin expressed in B. thuringiensis shows decreased mortality to early fourth instar larvae of A. aegypti, An. stephensi and C, quinquefasciatus.
Mosquito larvae Wild-type Cry11Ba L1-R303A/E304A/N305A
LC50 (ng/ml) LC95 (ng/ml) LC50 (ng/ml) LC95 (ng/ml)
Ae. aegypti 7.86 (5.1–11.1) 85.2 (48.4–234.5) 2176 (1389–3432) 29210 (15111–79822)
An. stephensi 2.2 (1.02–2.9) 5.8 (4.3–14.5) 3128 (2028–4841) 33382 (17850–89189)
C. quinquefasciatus 3.3 (2.1–4.4) 12.3 (8.8–23.9) 9249 (6138–13989) 73702 (40956–194201)
() Represents upper and lower 95% conﬁdence limits.
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Fig. 3. Processing of the puriﬁed mutants toxins and its CD spectra show the structures of mutant toxins are not substantially different from the wild-type Cry11Ba. (A) SDS–
PAGE of ion exchange puriﬁed mutant toxin (a8-V256A/G257A/E258A) from E. coli, lane 1. Lanes 2 and 3 are trypsinized puriﬁed toxins for a8-V256A/G257A/E258A and L3-
N454A/K455A/L456A, respectively, showing formation of 35- and 30-kDa fragments. (B) CD spectra of the puriﬁed and activated Cry11Ba toxin (j) in comparison with that of
the mutant V256A/G257A/E258A () and L3-N454A/K455A/L456A (N).
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(Table 2), suggesting a negligible improper folding and structure.
Thus far, the evidence suggests that the reduction in toxicity of
the Cry11Ba mutants is unlikely due to changes in protein folding
after alanine substitutions.3.6. Effect of loop mutations on binding to BBMV
We then used two puriﬁed loop 1 mutants (R303A/E304A/N305
and H307A) on loop 1 that were expressed in B. thuringiensis to
assess if they could compete with binding of biotinylated-Cry11Ba
S. Likitvivatanavong et al. / FEBS Letters 583 (2009) 2021–2030 2027to BBMV. Even though both mutants could compete with binding
of Cry11Ba (Fig. 2, lanes 10 and 11), one (H307A) retained toxicity
(Table 2), while the other (R303A/E304A/N305) lost toxicity (see
Table 3).
3.7. In situ binding analysis and competitive binding assays in the
presence of anti-cadherin antibody
For in situ competitive assays, we determined Cry11Ba binding
to dissected Ae. aegypti midgut in the absence or presence of syn-
thetic peptide competitors (L1 and L2). The results show that lower
Cry11Ba binding was observed on the microvilli regions when
competed with the L1 loop peptide (Fig. 4A, panels C1–2 and
Fig. 4B, and panels C1–2). In contrast, the L2 peptide showed lower
levels of competition with Cry11Ba (Fig. 4A panel D and Fig. 4B pa-
nel B). These data directly corroborate data above that show loop 1
peptides are capable of competing Cry11Ba toxin binding to larval
midgut BBMV while the loop 2 peptide does not compete.
We also analyzed the Cry11Ba binding pattern in Aedes larval
midgut. Using a similar approach as above we analyzed Cry11Ba
binding regions in tissue sections of larval midgut which were
incubated with puriﬁed Cry11Ba. Intense immunoﬂuorescence
was observed in the apical microvilli of posterior midgut epithelial
cells (Fig. 4A) as well as in caecae (Fig. 4B). No Cry11Ba binding was
observed in the anterior midgut (Fig. 4A, panel B) or hindgut cells
(data not shown). Control larval midgut sections in which the acti-
vated Cry11Ba toxin was omitted showed no immunoﬂuorescence
on the apical microvilli membrane of caecae (Fig. 4B, panel A). A
similar expression proﬁle is also observed when midgut tissue sec-
tions are analyzed with anti-Aedes cadherin antibodies (Chen,
Aimanova and Gill, unpublished data). From the data we expect
Aedes cadherin is a likely candidate for Cry11Ba toxin binding. To
strengthen this notion, we performed competitive binding of the
Cry11Ba toxin to Aedes BBMV in the presence of anti-cadherin anti-
body and a control anti-NHE antibody. Fig. 5 shows the anti-cad-
herin antibody competes with Cry11Ba toxin binding to BBMV
even in the presence of a 1:1000 dilution whereas anti-NHE8 anti-
body had little ability to compete with the Cry11Ba toxin binding.4. Discussion
Cry11Ba toxin is one of the most toxic single Bacillus proteins to
mosquito larvae. However, little is know about the structure of this
toxin or its loop regions. Based on information gathered from the
resolved Cry toxin structures and site-directed mutagenesis stud-
ies [21,23,44] domain II has been identiﬁed as primarily responsi-
ble for toxin selectivity to particular insects. Using the Cry2Aa
structure [33] we made a homology structure of Cry11Ba toxin
including the predicted loop regions of domain II.
Upon proteolytic activation, the 65-kDa Cry11Ba toxin gener-
ates 30- and 35-kDa fragments. A previous study with Cry11Bb1
proteins [45] shows the N-terminal fragment is the smaller of
the two proteolytic fragments. Although not conﬁrmed here with
Cry11Ba the 35-kDa protein is likely the C-terminal fragment,
which is composed of most of domain II and domain III, since in
this work it preferably competes in binding on BBMV of Ae. aegypti
(Figs. 2 and 5 & Table 1). Moreover it has been reported that do-
main III of several Cry toxins is also involved in receptor binding
[46–48]. For example, replacement of domain III in CrylAb and Cry-
lAc with domain III of Cry1Ca, resulted in increased toxicity to-
wards Spodoptera exigua and altered membrane protein
recognition [49]. In addition, the 2l-kDa Cry4Ba-domain III frag-
ment binds the apical midgut microvilli of Ae. aegypti but it has
lower-binding capability when compared to the 43-kDa Cry4Ba-
domain II–III fragment [25,50]. Therefore, the receptor bindingcapability of Cry toxins is contributed mostly by domain II rather
than domain III, even though the latter can be involved in binding.
In this report we demonstrate that three of the predicted loop
regions, loop a8, loop 1 and loop 3, are involved in binding ability
to Aedes BBMV. Loop a8 and loop 3 of Cry11Aa toxin are similarly
involved in binding to toxin receptors in Aedes BBMV [24]. Loop a8,
loop 2 and loop 3 of CrylAb have been suggested to play a role in
toxin binding to Manduca sexta Bt-Rl [26,51,52] whereas only loop
2 and loop 3 of CrylAc are involved in binding to the cadherin
receptor [53]. In addition, loop 1 and loop 3 of Cry3A have been re-
ported in binding Tenebrio molitor BBMV [32]. The difference in
binding ability of loops in different Cry toxins might be due to
the fact that domain II is the most variable region of the toxin do-
mains, and it is especially true for the apex loops [20,21,38,39].
Thus, differences in sequence, length, and conformation of the
loops are believed to be key determinants of toxin selectivity.
We then show that the mutations of amino acid residues of loop
a8, loop 1 and loop 3 affect the toxicity of Cry11Ba towards Aedes
and Culex mosquito larvae whereas loop a8 appears to be the pri-
mary determinant for toxicity against Anopheles sp. These data
are supported by competition experiments using loop peptides.
For example, loop a8, loop 1 and loop 3 peptides all compete well
with Cry11Ba binding to BBMV (Table 1, Fig. 2). Thus not surpris-
ingly mutations in these loops also demonstrated a loss of mosqui-
tocidal activity.
When the binding ability was tested with the two puriﬁed loop
1 mutants expressed in Bacillus, we show that they could compete
with the Cry11Ba binding. The ability of the mutant H307A to com-
pete is not surprising since it retained toxicity. But the ability of the
R303A/E304A/N305 mutant to compete with Cry11Ba binding to
Aedes BBMV was unexpected since this mutant had much lower
toxicity. The data implies that amino acid residues 303-305 of loop
1, which are important for toxicity, are not as affected in receptor
binding ability. However, these residues might be involved in sub-
sequent steps such as membrane insertion and/or pore-forming
activity. As previous reported, residue G312 of loop 1 of Cry1Ac
had no signiﬁcantly effect on BBMV binding ability but was af-
fected in toxicity [31]. It is conceivable that residues in domain II
are not always involved in receptor binding. For example, the
Cry1Ab F371 loop mutant lost its ion channel activity instead of
binding activity suggesting a role for this residue in membrane
insertion [54,55].
In addition we determined Cry11Ba binding to dissected Ae. ae-
gypti midgut in the absence or presence of synthetic loop peptide
competitors (L1 and L2). The results are similar to competitive tox-
in binding assays in which loop peptides a8, L1 and L3 compete
with Cry11Ba binding to BBMV whereas loop peptide L2 does not
compete. We also show the Cry11Ba binding pattern in tissue sec-
tions of Aedes larval midgut is similar to previous tissue binding
studies of several Cry toxins (i.e. Cry4Aa, Cry4Ba, Cry11Aa), which
show toxin binding is located to the apical microvilli of the larval
midguts [56]. The binding pattern is also similar to that observed
with Cry11Aa and Cry11Bb toxins [16,57]. Previous work has dem-
onstrated that an alkaline phosphatase (ALP) is localized on the
apical side of distal and proximal caecae and apical regions of pos-
terior midgut [16]. A similar expression proﬁle is also observed
when midgut tissue sections are analyzed with anti-Aedes cad-
herin antibodies (Chen, Aimanova and Gill, unpublished data).
The binding pattern of ALP and cadherin antibodies is consistent
with Cry11Ba toxin binding in Aedes larval guts. From this data
we can conclude that either ALP and cadherin, or more likely both,
could bind Cry11Ba toxin and they might be involved in the mech-
anism of Cry11Ba toxiﬁcation.
In this report we also provide evidence of Aedes cadherin anti-
body inhibiting the binding of Cry11Ba toxin. The ability of the
Cry11Ba to bind Aedes cadherin is not surprising since cadherins
Fig. 4. The Cry11Ba toxin binds the apical membrane in caeca and posterior midgut of larval Ae. aegypti and a loop peptide competes with this binding. (A) Merged midgut
sections of 4th instar larvae showing anti-Cry11Ba immunoreactivity (Cy3, red) and Phalloidin (Alexa-488, green); (A1, A2) anti-Cry11Ba reactivity in the apical membrane of
posterior midgut; (B) no immunoreactivity was observed in the apical membrane of anterior midgut; (C1, C2) competition binding assay of Cry11Ba to the posterior midgut
region using synthetic peptide L1 (C1, C2) and L2 (D) as competitors. Scale bar 10 lm. (B) Competition binding assay in Aedes aegypti gastric caecae cells using Cry 11Ba toxin
and the L1 and L2 peptides as competitors. Anti-Cry11Ba immunoreactivity was detected in the apical membrane of gastric caeca cells (B, C1, C2); (B) competitor peptide L2;
(C1, C2) competitor peptide L1. (A) No immunoreactivity in the apical membrane of gastric caeca epithelial cells when the tissues were probed with only the preimmune
serum. Scale bar 50 lm.
2028 S. Likitvivatanavong et al. / FEBS Letters 583 (2009) 2021–2030are important receptors for Cry1A toxins in many lepidopteran in-
sects [5,58,59]. Recent studies shown the cadherin protein is also
important for binding Cry4B in An. gambiae [13] and the Cry11Aa
in Ae. aegypti (Chen, Aimanova and Gill, unpublished data). Since
the majority of Cry toxins appear to bind cadherin-liked protein,
the cadherin protein is also a likely receptor protein for the Cry11Ba
toxin.
Overall, the data reveal three loops (loop a8, loop 1 and loop 3)
in domain II of Cry11Ba are involved in toxicity against mosquitolarvae, with loop 1 and loop 3 being of greater signiﬁcance to Aedes
and Culex larvae than to Anopheles larvae. Considering the loop re-
gions of domain II are the most variable of the toxin domains, these
regions are important determinants in toxin selectivity. Three loop
peptides were observed to compete with Cry11Ba binding activity
on Aedes BBMV. As for Aedes, the loss of toxicity observed in loop
a8, loop 1 and loop 3 mutants might correspond to the loss of toxin
binding ability as observed in competitive assays in which loop
peptides a8, L1 and L3 compete with Cry11Ba binding to BBMV.
35
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Fig. 5. The anti-Aedes cadherin antibody competes with Cry11Ba binding to BBMV.
Lane 1, biotinylated-Cry11Ba toxin was incubated with BBMV in the presence of
unlabeled Cry11Ba; lanes 2 and 3 biotinylated-Cry11Ba toxin incubated with BBMV
in the presence of different dilutions of anti-Aedes cadherin antibody (1:1000, 1:10,
respectively); lanes 4 and 5, similar experiments in the presence of anti-Aedes
NHE8 antibody (1:1000, 1:10, respectively).
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